Astellas Pharma | 4503 - Gross Profit On Sales


Astellas Pharma reported JPY444.26B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Astellas Pharma JPY 444.26B 12.55B Mar/2026
Chugai Pharma JPY 258.74B 25.81B Dec/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Eisai JPY 168.85B 17.02B Dec/2025
Kyowa Hakko Kirin JPY 109.5B 18.9B Dec/2025
M3 JPY 47.97B 6.56B Dec/2025
Otsuka Holdings JPY 456.25B 1.16B Mar/2026
Shionogi JPY 122.63B 26.38B Dec/2025
Sumitomo Dainippon JPY 73.53B 7.55B Sep/2025
Takeda JPY 790.55B 262.97B Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025